Update on novel pharmacological therapies for osteoarthritis

by Asim Ghouri, Philip G. Conaghan
Published 2019-07-01

Comparison of 3D quantitative osteoarthritis imaging biomarkers from paired CT and MR images: data from the IMI-APPROACH study

by Alan Brett, Michael A. Bowes, Philip G. Conaghan
Published 2023-01-01

Impact of tanezumab on health status, non-work activities and work productivity in adults with moderate-to-severe osteoarthritis

by Philip G. Conaghan, Lucy Abraham, Lars Viktrup, Paul Cislo
Published 2022-02-01

The role of the NLRP3 inflammasome in gout

by Sarah R Kingsbury, Philip G Conaghan, Michael F McDermott
Published 2011-03-01

The prevalence and impact of self-reported foot and ankle pain in the over 55 age group: a secondary data analysis from a large community sample

by Anne-Maree Keenan, Chris Drake, Philip G. Conaghan, Alan Tennant
Published 2019-11-01

Effectiveness and safety of polyacrylamide hydrogel injection for knee osteoarthritis: results from a 12-month follow up of an open-label study

by Henning Bliddal, Jannie Beier, Andreas Hartkopp, Philip G. Conaghan, Marius Henriksen
Published 2024-05-01

The effect of targeted treatment on people with patellofemoral pain: a pragmatic, randomised controlled feasibility study

by Benjamin T. Drew, Philip G. Conaghan, Toby O. Smith, James Selfe, Anthony C. Redmond
Published 2017-08-01

Rescue Analgesic Medication Use by Patients Treated with Triamcinolone Acetonide Extended-Release for Knee Osteoarthritis Pain: Pooled Analysis of Three Phase 2/3 Randomized Clinic...

by Alan J. Kivitz, Philip G. Conaghan, Amy Cinar, Joelle Lufkin, Scott D. Kelley
Published 2019-05-01

A home exercise programme is no more beneficial than advice and education for people with neurogenic claudication: results from a randomised controlled trial.

by Christine Comer, Anthony C Redmond, Howard A Bird, Elizabeth M A Hensor, Philip G Conaghan
Published 2013-01-01

Cost-effectiveness of hydroxychloroquine versus placebo for hand osteoarthritis: economic evaluation of the HERO trial [version 1; peer review: 2 approved]

by Catherine Arundel, David J Torgerson, Sarah J Ronaldson, Ada Keding, Puvan Tharmanathan, Sarah R Kingsbury, Philip G Conaghan
Published 2021-08-01

Imaging in rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and osteoarthritis: An international viewpoint on the current knowledge and future research prioritie...

by Xenofon Baraliakos, Philip G. Conaghan, Maria-Antonietta D'Agostino, Walter Maksymowych, Esperanza Naredo, Mikkel Ostergaard, Georg Schett, Paul Emery
Published 2019-01-01

Increasing Capacity for the Treatment of Common Musculoskeletal Problems: A Non-Inferiority RCT and Economic Analysis of Corticosteroid Injection for Shoulder Pain Comparing a Phys...

by Darryn Marks, Leanne Bisset, Tracy Comans, Michael Thomas, Shu Kay Ng, Shaun O'Leary, Philip G Conaghan, Paul A Scuffham
Published 2016-01-01

Long-term health conditions and UK labour market outcomes during the COVID-19 pandemic

by Edward J. D. Webb, Philip G. Conaghan, Max Henderson, Claire Hulme, Sarah R. Kingsbury, Theresa Munyombwe, Robert West, Adam Martin
Published 2024-01-01

Variation in methods, results and reporting in electronic health record-based studies evaluating routine care in gout: A systematic review.

by Samantha S R Crossfield, Lana Yin Hui Lai, Sarah R Kingsbury, Paul Baxter, Owen Johnson, Philip G Conaghan, Mar Pujades-Rodriguez
Published 2019-01-01

Prediction of flare following remission and treatment withdrawal in early rheumatoid arthritis: post hoc analysis of a phase IIIb trial with abatacept

by Harris A. Ahmad, Joshua F. Baker, Philip G. Conaghan, Paul Emery, Thomas W. J. Huizinga, Yedid Elbez, Subhashis Banerjee, Mikkel Østergaard
Published 2022-02-01

Disease modification in osteoarthritis; pathways to drug approval

by Jeffrey N. Katz, Tuhina Neogi, Leigh F. Callahan, Joel A. Block, Philip G. Conaghan, Lee S. Simon, Virginia Byers Kraus, Marc C. Hochberg
Published 2020-06-01

Effect size varies based on calculation method and may affect interpretation of treatment effect: an illustration using randomised clinical trials in osteoarthritis

by Thomas J. Schnitzer, Philip G. Conaghan, Francis Berenbaum, Lucy Abraham, Joseph C. Cappelleri, Andrew G. Bushmakin, Lars Viktrup, Ruoyong Yang, Mark T. Brown
Published 2024-04-01

UK poSt Arthroplasty Follow-up rEcommendations (UK SAFE): what does analysis of linked, routinely collected national data sets tell us about mid-late term revision risk after hip r...

by Philip G Conaghan, Andrew Judge, Sarah R Kingsbury, Nigel K Arden, Rafael Pinedo-Villanueva, Lindsay K Smith, Cesar Garriga, Antonella Delmestri, Martin Stone
Published 2022-03-01

Association between outpatient follow-up and incidence of revision after knee and hip replacements: a population-based cohort study

by Rafael Pinedo-Villanueva, Spyros Kolovos, Edward Burn, Antonella Delmestri, Lindsay K. Smith, Andrew Judge, Sarah R. Kingsbury, Martin H. Stone, Philip G. Conaghan
Published 2023-02-01

Mid- to late-term follow-up of primary hip and knee arthroplasty: the UK SAFE evidence-based recommendations

by Sarah R. Kingsbury, Lindsay K. K. Smith, Rafael Pinedo-Villanueva, Andrew Judge, Robert West, Judy M. Wright, Martin H. Stone, Philip G. Conaghan
Published 2023-02-01